McDermott Will & Emery
Subscribe to McDermott Will & Emery's Posts5 Questions with a Health Lawyer: Sharon Lamb
By McDermott Will & Emery on Mar 31, 2022
Posted In Uncategorized
Sharon Lamb Practice Focus Area: Health and Life Sciences Office: London Years at Firm: 4 What is your favorite part about practicing health and life sciences law at McDermott? This is an easy question to answer! McDermott has a truly international health and life sciences practice with talented lawyers with deep expertise across all disciplines...
Continue Reading
5 Questions with a Health Lawyer: Dr. Deniz Tschammler
By McDermott Will & Emery on Mar 28, 2022
Posted In Uncategorized
Dr. Deniz Tschammler Practice Focus Area: Health and Life Sciences Office: Munich/Frankfurt Years at Firm: 2 What is your favorite part about practicing healthcare law at McDermott? Apart from exciting clients and projects, a great privilege of my work at McDermott is to closely collaborate with a wide range of inspiring and outstanding health and...
Continue Reading
5 Questions with a Health Lawyer: Brian Hall
By McDermott Will & Emery on Feb 24, 2022
Posted In Uncategorized
Brian Hall Practice Focus Area: Healthcare Transactions & Regulatory Office: Washington, DC Years at Firm: 3+ years What is your favorite part about practicing healthcare law at McDermott? It’s easily the colleagues I work with on daily basis. I’m fortunate that my practice requires me to work with attorneys across the entire Healthcare practice group...
Continue Reading
5 Questions with a Health Lawyer: Caroline Reigart
By McDermott Will & Emery on Feb 3, 2022
Posted In Uncategorized
Caroline Reigart Practice Focus Area: Fraud & Abuse and Reimbursement Office: Washington, DC Years at Firm: 2.5 What is your favorite part about practicing healthcare law at McDermott? McDermott is fortunate to be on the cutting edge of many of the legal issues that shape the healthcare industry. My favorite part of practicing healthcare law...
Continue Reading
McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: European Healthcare Private Equity Forum
By McDermott Will & Emery on Jan 14, 2022
Posted In Health Private Equity, International Health, Uncategorized
With continued growth in healthcare global investing, what role do European markets play in global and US fund portfolios and to what extent do investments benefit from a transatlantic portfolio? Sharon Lamb, Partner at McDermott, was joined by Marco Bonaiti, Vice President at Apax Partners; Tony Drabble, Partner at EY-Parthenon; Henry Elphick, Deputy Chair of...
Continue Reading
McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: Hospitals and Health Systems Forum
By McDermott Will & Emery on Jan 13, 2022
Posted In Hospitals & Health Systems, Life Sciences, Uncategorized
A series of panels co-hosted by EY and McDermott Will & Emery during the 2022 J.P. Morgan Healthcare Conference examined how hospitals and health systems continue to weather the pandemic. Leaders from the health system perspective looked at heightened cost pressures, resource strains and demands for better technology experiences, as well as innovative and collaborative...
Continue Reading
McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: Acceleration Capital
By McDermott Will & Emery on Jan 12, 2022
Posted In Digital Health, Health Private Equity, Uncategorized
Digital health has never been hotter, and investor interest is surging across all stages. From early- to late-stage investments, lines are blurring with increased disruption in the digital health landscape. Traditional private equity and growth investors are moving earlier in the cycle in an attempt to capture the next unicorn, and venture capital investors are...
Continue Reading
McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: Healthcare Private Equity Leaders Forum
By McDermott Will & Emery on Jan 12, 2022
Posted In Health Private Equity, Uncategorized
During this session, leading private equity investors explored key drivers and trends across diverse industry subsectors. They examined how shifting regulations and the upcoming 2022 midterm elections may alter the deal landscape and mapped out strategies for adapting and thriving amid change. Panelists also offered their exclusive insights into emerging opportunities in health information technology...
Continue Reading
McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: Digital Health Pioneers Forum
By McDermott Will & Emery on Jan 11, 2022
Posted In Digital Health
The past two years saw continued growth in the digital health sector. During the virtual Digital Health Pioneers Forum hosted by McDermott and EY at the 2022 J.P. Morgan Healthcare Conference, industry leaders discussed the potential impact of disruptive forces such as artificial intelligence (AI) and tech-enabled healthcare; how data and analytics could reduce disparities...
Continue Reading
McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: Life Sciences Investment Forum
By McDermott Will & Emery on Jan 10, 2022
Posted In Life Sciences, Uncategorized
Despite offering one of the lowest total deal values on record, 2021 was an active M&A year. Due to the strong capital markets, a seller’s market continued, creating additional urgency for biopharma companies to accelerate their partnership agendas, especially to access new modalities that are likely to be the cornerstone of future growth. The past...
Continue Reading
